{"id":178604,"date":"2026-01-15T07:37:00","date_gmt":"2026-01-15T12:37:00","guid":{"rendered":"https:\/\/testing.news-you-need.com\/index.php\/2026\/01\/15\/automation-joins-ai-and-cybersecurity-as-digital-priorities-for-indian-pharma\/"},"modified":"2026-01-15T07:45:16","modified_gmt":"2026-01-15T12:45:16","slug":"automation-joins-ai-and-cybersecurity-as-digital-priorities-for-indian-pharma","status":"publish","type":"post","link":"https:\/\/testing.news-you-need.com\/index.php\/2026\/01\/15\/automation-joins-ai-and-cybersecurity-as-digital-priorities-for-indian-pharma\/","title":{"rendered":"Automation joins AI and cybersecurity as digital priorities for Indian pharma"},"content":{"rendered":"

Automation joins AI and cybersecurity as digital priorities for Indian pharma<\/a><\/p>\n

https:\/\/www.europeanpharmaceuticalreview.com\/news\/270281\/automation-ai-cybersecurity-digital-transformation-india-pharma\/<\/a><\/p>\n

Publish Date: 2026-01-15 07:37:00<\/a><\/p>\n

Source Domain: www.europeanpharmaceuticalreview.com<\/a><\/p>\n

Author: <\/a><\/p>\n

Using an unordered list, summarize the following article with between 4 and 8 key points. But the sector\u2019s digital transformation ambitions within their quality functions have only been partially realised.
\nThe Indian pharma sector has an increasing number of technological priorities underpinning its digital transformation plans, but those ambitions have only partially been realised.That\u2019s according to a new report by Archimedis Digital, which outlines companies\u2019 emerging technology priorities, identifying automation, AI, cybersecurity, data analytics and cloud computing as critical enablers of efficiency and quality excellence.Duraisamy Rajan Palani, Founder and CEO at Archimedis Digital, said: \u201cAs life sciences companies confront increasingly complex regulatory environments, rising customer expectations and rapid technological change, digital transformation is no longer optional \u2013 it\u2019s foundational for growth, resilience and competitive differentiation.\u201dArchimedis Digital\u2019s report found that only a third of companies assessed had achieved significant or full digital transformation within their quality functions, with more than half (55.6 percent) having only reached partial implementation of their plans.Nevertheless, the Chennai, India-based consultancy did note that few pharma firms have made little or no progress on their digital journey \u2013 with just 2.2 percent having not started and 8.9 percent only having made it to the planning phase.The Indian pharma sector makes a vital contribution to the production and supply of generic medicines and, increasingly, is also important as a hub for novel drug research.However, Archimedis Digital notes that companies are being pushed to move beyond traditional paper-based systems and adopt integrated, data-driven digital quality ecosystems in response to rising regulatory scrutiny, growing product and process complexity, and intensifying global competition.\u201cThis transition, while still fragmented, signals the industry\u2019s readiness to build a robust digital data foundation required for AI and ML-led quality transformation,\u201d the company noted.One of the areas highlighted by Archimedis Digital where digital technology could add value was in managing rising product and process complexity \u2013 particularly as newer modalities move further into the pharma mainstream.\u201cAs drug development increasingly involves complex biologics, combination products, and stringent GMP requirements, legacy system limitations and integration challenges remain key barriers. Technologies such as electronic batch manufacturing records (eBMRs) and lab automation are emerging as foundational tools for managing complexity with greater precision and control,\u201d the company said.
<\/p>\n","protected":false},"excerpt":{"rendered":"

Automation joins AI and cybersecurity as digital priorities for Indian pharma https:\/\/www.europeanpharmaceuticalreview.com\/news\/270281\/automation-ai-cybersecurity-digital-transformation-india-pharma\/ Publish Date: 2026-01-15…<\/p>\n","protected":false},"author":1,"featured_media":178605,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/www.europeanpharmaceuticalreview.com\/wp-content\/uploads\/automation-2.jpg","fifu_image_alt":"","footnotes":""},"categories":[15],"tags":[26,24],"class_list":["post-178604","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cybersecurity","tag-ai","tag-cybersecurity"],"_links":{"self":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/178604"}],"collection":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/comments?post=178604"}],"version-history":[{"count":1,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/178604\/revisions"}],"predecessor-version":[{"id":178606,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/178604\/revisions\/178606"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/media\/178605"}],"wp:attachment":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/media?parent=178604"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/categories?post=178604"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/tags?post=178604"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}